|
WO2007118889A1
|
|
Specific protease for inactivation of human tumour necrosis factor-alpha
|
|
EP1881067A1
|
|
Mannanases
|
|
EP1847600A1
|
|
Specific protease for inactivation of human tumour necrosis factor-alpha
|
|
EP1827486A2
|
|
Targeted use of engineered enzymes
|
|
EP1726643A1
|
|
Method for the provision, identification and selection of proteases with altered sensitivity to activity-modulating substances
|
|
AU2004249904A1
|
|
New biological entities and the pharmaceutical or diagnostic use thereof
|
|
US7170598B2
|
|
Multi-parameter fluorimetric analysis in a massively parallel multi-focal arrangement and the use thereof
|
|
US2004132054A1
|
|
Method for the selective combinatorial randomization of polynucleotides
|
|
US2004072276A1
|
|
Process for generating sequence-specific proteases by directed evolution and use thereof
|
|
EP1411345A1
|
|
Multi-parameter fluorimetric analysis in a parallel multi-focal arrangement
|
|
EP1394251A1
|
|
Method for the selective randomization of polynucleotides
|
|
EP1361284A1
|
|
Process for generating sequence-specific proteases by directed evolution and use thereof
|
|
EP1321513A1
|
|
Subtilisin variants with improved characteristics
|
|
EP1281757A1
|
|
Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids
|
|
EP1262545A1
|
|
Microstructures and the use thereof in the targeted evolution of biomolecules
|
|
EP1217375A1
|
|
Solid phase substrate for structured reaction substrates
|
|
DE10038382A1
|
|
Two-color fluorimetric protease assay
|
